Pharmacokinetics and Safety of Sodium Benzoate, a d-Amino Acid Oxidase (DAAO) Inhibitor, in Healthy Subjects: A Phase I, Open-label Study-Reference-Cited by-同舟云学术

Pharmacokinetics and Safety of Sodium Benzoate, a d-Amino Acid Oxidase (DAAO) Inhibitor, in Healthy Subjects: A Phase I, Open-label Study

Published:2022-10 Issue:10 Volume:44 Page:1326-1335
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Lin Yen-Shan,Mao Wei-Chung,Yao Nai-Tzu,Tsai Guochuan Emil

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference42 articles.

1. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;American Journal of Psychiatry,2005

2. Antipsychotic prescribing patterns in first-episode schizophrenia: a five-year comparison;Roh;Clinical Psychopharmacology and Neuroscience,2015

3. Understanding schizophrenia as a disorder of consciousness: biological correlates and translational implications from quantum theory perspectives;Venkatasubramanian;Clinical Psychopharmacology and Neuroscience,2015

4. Antipsychotic drugs, neurotransmitters, and schizophrenia;Carlsson;American Journal of Psychiatry,1978

5. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values;Meltzer;Journal of Pharmacology and Experimental Therapeutics,1989

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Add-on Sodium Benzoate and N-Acetylcysteine in Patients With Early Schizophrenia Spectrum Disorder: A Multicenter, Double-Blind, Randomized Placebo-Controlled Feasibility Trial;Schizophrenia Bulletin Open;2024-01-01

2. The Effect of Sodium Benzoate on Host Health: Insight into Physiological Indexes and Gut Microbiota;Foods;2023-11-10